# Brooklyn Immunotherapeutics Investors LP — Form D

Brooklyn Immunotherapeutics Investors LP of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-19. The offering totals $21.2M, of which $21.2M was reported sold. Industry: Investing.

## Offering

- Filed: 2018-11-19
- Form: D
- Accession: 0000908662-18-000228
- Industry: Investing
- Exemptions: 06b, 3C, 3C.1
- Total offering: $21.2M
- Amount sold: $21.2M
- Remaining: $67K
- Investors: 85
- Date of first sale: 2018-11-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326067

## Issuer

- Name: Brooklyn Immunotherapeutics Investors LP
- CIK: 0001758682
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 109 N. POST OAK LANE, SUITE 530, HOUSTON, TX, 77024
- Phone: 713-337-9150

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| N/A Brooklyn Immunotherapeutics Investors GP LLC | Director | Houston, TX |
| Charles R Cherington | Director | Houston, TX |
| George P Denny III | Director | Houston, TX |

## More

- [CIK 1758682 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1758682&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000908662-18-000228.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.